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Intravascular ultrasound (IVUS) depicts large amounts of information about the vessel and lesion characteristics. It is a promising tool to improve the quality of endovascular treatment (EVT). Recent studies have shown the usefulness of IVUS in percutaneous coronary intervention^[@bib1])^. However, evidence remains insufficient regarding the clinical impact of IVUS in EVT for peripheral arterial disease (PAD), particularly for challenging femoropopliteal (FP) lesions. In this issue of *Journal of Atherosclerosis and Thrombosis*, Mori *et al* reported the clinical outcomes of bare-metal stent (BMS) implantation for long occlusive FP lesions using the IVUS-guided intraluminal approach^[@bib2])^. They revealed that 1) only one-third of the cases successfully underwent intraplaque (i.e., intraluminal) angioplasty using a 0.014-inch guidewire under IVUS guidance and 2) two IVUS findings, a long intramedial route and a small distal lumen area, were predictors of restenosis. Long occlusive FP lesions are not rare in symptomatic PAD and their study is very informative for considering the treatment strategy of these challenging lesions.

In clinical practice, it was generally believed that 0.014-inch guidewires opened up an intraluminal route in lesions with chronic total occlusion (CTO). Angioplasty using a 0.014-inch guidewire was, therefore, often deemed to be a synonym of intraluminal angioplasty and was widely used. However, as depicted in this study, this belief was just a delusion; majority of cases failed to achieve perfect intraluminal angioplasty, and instead underwent at least partial subintimal or intramedial angioplasty. We must now recognize that angioplasty using a 0.014-inch guidewire is not equal to intraluminal angioplasty, but is just an intraluminal approach; it simply serves as a strategy aiming at intraluminal angioplasty.

They additionally demonstrated that intramedial angioplasty was associated with an increased risk of restenosis. Their findings suggest that avoiding intramedial angioplasty could further improve the patency after EVT. Given that the approach using a 0.014-inch guidewire itself does not guarantee perfect intraluminal angioplasty and cannot completely prevent intramedial angioplasty, the technical development of new approaches to guidewire crossing is greatly desired.

Another risk factor of restenosis was a small vessel, which was consistent with the results observed in previous studies. They reported that the optimal cutoff point was a distal lumen area of 17.7 mm^2^, which corresponded to 4.7 mm in diameter. Similar to the case of coronary artery intervention, a small vessel is still a major obstacle in the peripheral endovascular intervention procedure^[@bib3])^. Given that vessel diameters smaller than 4.7 mm are not rare in Japanese PAD patients, the issue is all the more practical and important. Endovascular techniques remain to be improved to such an extent that favorable outcomes would be guaranteed even for these small vessels.

IVUS undeniably illustrates a lot of information. We must not only exploit IVUS images for the best EVT in individual cases but also carefully collect and analyze data to build accurate knowledge about which measurements would be associated with clinical outcomes. These findings would be vital for risk stratification at present, and for procedural development and improvement in future.
